Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, October 23, 2026

Back to today

Research & Analysis: ERock, Inc. (NYSE: EROC)

ERock’s modular microgrids bridge data-center power gaps years before grid interconnects, with Meta and Anthropic projects filling capacity through early 2028.

EROC $453M
Monte Independent Investment Research 7 clicks

From X

@BrokenMoats

Broken Moats on X

Interesting to see $V up 9 days in a row (nearly funtrun the Chinese announcement). While a positive, it will be years before it plays out (if China follows through down the line, and gets them in the same place AXP and MA already were + the domestic competition). But thats incremental and down the road at best the focus though should be the support the administration (trump recently, and JD wrote the bill when in congress) has thrown behind the CCCA as well as additional bipartisan sponsors that signed on in the past few weeks....that bill will open the rails to an additional network. Which would be a very big additional push towards stable coin based transactions (even greater push from agents commerce). Ultimately the power is shifting towards merchants that no longer want to be subjected to 3%+ interchange fees. If $V losses the CCCA and pandoras box on competition is opened their entire moat is at stake, similar to what is going on with $FICO and Vantage. A once unassailable business model could very quickly come under pressure. Australia lowered interchange fees, went in to effect Oct. 1.....the pressure is building worldwide. But it's the cracking the door open in addition to a new way of shopping that could really leave $V disrupted. Not a mistake the first move earlier this year was lower on the back of AI fears, it has bounced with software now where somehow Phone systems from $RNG and website domains from $GDDY are somehow the new "hot trade", but secular trends seem obvious regardless of pacing that Visa and its pricing power and duopoly are in trouble and FICO to me is a similar case study.
@convequity

Convequity on X

We own both $ONTO and $CAMT because they sell overlapping tools to different HBM makers, and we raised Onto while holding Camtek. In our 4Q26 portfolio rebalance we increased Onto in our portfolio and held Camtek unchanged. Inspection identifies defects. Metrology measures dimensions and material properties to check that manufacturing meets specifications. Both companies sell inspection and metrology tools for HBM and advanced packaging, but their customer exposure differs. Onto is more closely tied to SK hynix's capital-spending plans. Our industry information identifies Camtek as a preferred supplier for Samsung's HBM production lines, and Samsung is investing aggressively to catch up with SK hynix in HBM. Camtek is smaller and more specialized, and we see a technical edge in selected HBM applications. Onto also sells chip-fabrication metrology and packaging lithography, which Camtek does not offer. We raised Onto because increasingly complex chip designs give customers reasons to keep investing beyond the current packaging recovery. We hold Camtek as the more focused advanced-packaging investment.

Investor Letters

All letters

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.5B
Latticework by MOI Global 28 clicks

Mosaic, Part Two: The Deep Dive

Mosaic, NYSE: MOS, is the subject of a second audio program for professional investors analyzing fertilizer producers.

MOS $5.5B
Latticework by MOI Global 4 clicks

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $108M
Triple S Special Situations Investing 4 clicks

Moon River Moly: Research Note

Moon River Moly’s updated Davidson PEA lifts after-tax NPV to $1.24 billion as flotation raises tungsten output 350% and cuts molybdenum…

MRIVF $16M
Atrium Research - Equity Research 4 clicks

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $291M
Guardian Research 4 clicks
PYPD · long

Polypid LTD

PolyPid, an $80 million Israeli biotech, fell nearly 30% despite solving a clinical problem.

PYPD $103M
Value Investors Club

Why I sold OB pick for 26 SVM

Silvercorp’s falling Ying grades, prolonged GC suspension, El Domo execution risk and Chaarat funding needs weaken its valuation despite…

SVM $2B
The Oak Bloke 27 clicks

Vicor Update, Part Three

Vicor’s $66.6 million in AI power-delivery royalties generated about $50 million of operating profit, eclipsing its module business as…

VICR $8.1B
CV's Substack 28 clicks

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $74M
Calvin Blissett 10 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 56 of 248

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.